Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
1-15 October 2008  
Untitled Document
Sections

Market
Management
Research
Pharma Life
 Packaging Special

Services
Open Forum
Appointments
Subscribe/Renew
Archives
Editorial Calendar
Media Kit
Contact Us
Network Sites
Express Computer
CIO Decisions
Express Channel Business
Express Hospitality
Express TravelWorld
feBusiness Traveller
Express Healthcare
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express




    RESEARCH - Expertise for Drug Development
 

The Low-down on Gefitinib
With the rising incidence of lung cancer there is an unmet need to provide effective therapy for advanced lung cancer that does not have the toxicity burden of conventional chemotherapy and radiotherapy. Divya Pamnani reviews Gefitinib as a treatment option for lung cancer, in addition to evaluating the research backing it up

Untitled Document
Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.